The original description of galectin-9 being preferentially expressed in the liver and localised close to the sinusoids [2], suggested that it could be ideally positioned to promote deletion or functional inactivation of Tim-3-expressing HBV-specific CD8 T cells as they infiltrate the site of infection. Here, CD8A is linked to infection.